RecruitingNCT03135730

International Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation & Autonomic Dysregulation (ROHHAD) Registry

International Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) REDCap Registry


Sponsor

Debra Weese-Mayer

Enrollment

1,000 participants

Start Date

Jun 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

The Center for Autonomic Medicine in Pediatrics (CAMP) has collaborated with doctors from around the world to build the first International ROHHAD (Rapid-onset Obesity with Hypothalamic Dysfunction, Hypoventilation and Autonomic Dysregulation) REDCap (Research Electronic Data Capture) Registry. This registry is an international collaboration with ROHHAD patients and their physicians recruited from around the world. The purpose of this IRB-approved research study is to gain a better understanding of the various health problems ROHHAD patients face with advancing age, and how these relate to each patient's specific medical course. With a better understanding of specific ROHHAD and associated clinical manifestations, we will be able to better anticipate healthcare needs and to provide more accurate guidelines to healthcare providers world-wide in caring for patients with ROHHAD. The study aims to obtain detailed phenotypic information (information about health and well-being) on patients with ROHHAD. Participation would require filling out a confidential survey that asks questions regarding health and past medical history. Involvement in the project is completely voluntary and there is no compensation for taking part. However, this project will help us learn more about this devastating disease, with the goal of advancing treatment.


Eligibility

Plain Language Summary

Simplified for easier understanding

This registry study collects detailed health information from patients around the world who have been diagnosed with ROHHAD — a rare and severe disorder in young children involving rapid weight gain, problems with the brain's control of breathing, and dysfunction of the autonomic nervous system. By building an international database, researchers hope to better understand how the condition progresses and how to improve care. Anyone with a confirmed or suspected clinical diagnosis of ROHHAD is eligible to participate regardless of age or location. Participation involves completing an online confidential survey about health history and medical course, with no requirement to travel or visit a clinic. This summary was prepared to help patients understand the study in plain language.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICROHHAD

Suspected and Confirmed ROHHAD cases


Locations(1)

Ann & Robert H. Lurie Children's Hospital of Chicago and the Stanley Manne Children's Research Institute

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03135730